Current and Future Role of Precision Medicine in the Management of IBD

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Current treatment options in gastroenterology

• Publication date

  2025-11-13

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s11938-025-00483-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?

  2025cited by this paper
• Relating the molecular phenotype of ulcerative colitis to the clinical course

  2025influential reference
• P0334 AGMB-129, an investigational ALK5 inhibitor for the treatment of Fibrostenosing Crohn’s Disease (FSCD), shows gastrointestinal (GI) restricted pharmacokinetics (PK) and a favorable safety profile in healthy subjects

  2025cited by this paper
• Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics study

  2025cited by this paper
• Global evolution of inflammatory bowel disease across epidemiologic stages

  2025cited by this paper
• Current Endoscopic Scoring Systems in Inflammatory Bowel Disease: Strengths and Limitations.

  2024cited by this paper
• Challenges in IBD Research 2024: Precision Medicine.

  2024cited by this paper
• Radiomics to Detect Inflammation and Fibrosis on Magnetic Resonance Enterography in Stricturing Crohn's Disease.

  2024influential reference
• Radiomics-Based Analysis of Intestinal Ultrasound Images for Inflammatory Bowel Disease: A Feasibility Study

  2024cited by this paper
• Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: a Randomized Controlled Trial.

  2024cited by this paper
• Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.

  2024cited by this paper
• Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab.

  2024cited by this paper
• NOD2 and Crohn’s Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired

  2024cited by this paper
• Artificial Intelligence in Inflammatory Bowel Disease.

  2024cited by this paper
• Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.

  2024cited by this paper
• Ancestral diversity in pharmacogenomics affects treatment for Hispanic/Latine populations with inflammatory bowel disease.

  2024cited by this paper
• A unique serum IgG glycosylation signature predicts development of Crohn’s disease and is associated with pathogenic antibodies to mannose glycan

  2024cited by this paper
• Preclinical Serological Signatures are Associated with Complicated Crohn's Disease Phenotype at Diagnosis.

  2023cited by this paper
• Deep Learning Models Capture Histological Disease Activity in Crohn’s Disease and Ulcerative Colitis with High Fidelity

  2023cited by this paper
• Incidence, Prevalence and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.

  2023cited by this paper
• Deep learning-based prediction model for diagnosing gastrointestinal diseases using endoscopy images

  2023cited by this paper
• Artificial‐intelligence‐based decision support tools for the differential diagnosis of colitis

  2023cited by this paper
• The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment

  2022cited by this paper
• Beyond Neutrophils for predicting relapse and remission in ulcerative colitis.

  2022cited by this paper
• Automatically detecting Crohn’s disease and Ulcerative Colitis from endoscopic imaging

  2022cited by this paper
• Approach to Treatment Failure in Inflammatory Bowel Disease.

  2022cited by this paper
• Histologic Healing in Inflammatory Bowel Disease.

  2022cited by this paper
• Immunomodulators: still having a role?

  2022cited by this paper
• Trans-ancestry, Bayesian Meta-analysis Discovers 20 Novel Risk Loci for Inflammatory Bowel Disease in an African American, East Asian, and European Cohort.

  2022cited by this paper
• A Canadian Provincial Screening Program for Lynch Syndrome

  2022cited by this paper
• Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy

  2022cited by this paper
• Rapid development of accurate artificial intelligence scoring for colitis disease activity using applied data science techniques

  2022influential reference
• Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn’s disease

  2022cited by this paper
• Development and Validation of a Deep Neural Network for Accurate Identification of Endoscopic Images From Patients With Ulcerative Colitis and Crohn's Disease

  2022cited by this paper
• Artificial intelligence enabled automated diagnosis and grading of ulcerative colitis endoscopy images

  2022cited by this paper
• Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn's Disease.

  2021cited by this paper
• Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta‐analysis

  2021cited by this paper
• Deep‐learning system for real‐time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis

  2021influential reference
• A Systematic Review of Monogenic Inflammatory Bowel Disease.

  2021cited by this paper
• Machine learning in medicine: what clinicians should know

  2021cited by this paper
• Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia.

  2021cited by this paper
• Cross-sectional imaging of intestinal barrier dysfunction by confocal laser endomicroscopy can identify patients with food allergy in vivo with high sensitivity

  2021cited by this paper
• Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease.

  2021cited by this paper
• Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel Disease

  2021cited by this paper
• DEEP LEARNING COMPUTER-AIDED POLYP DETECTION REDUCES ADENOMA MISS RATE: A U.S. MULTI-CENTER RANDOMIZED TANDEM COLONOSCOPY STUDY (CADeT-CS Trial).

  2021cited by this paper
• Deep neural network for video colonoscopy of ulcerative colitis: a cross-sectional study.

  2021cited by this paper
• Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

  2020cited by this paper
• Comparison of the Nancy index with continuous Geboes score: histological remission and response in ulcerative colitis.

  2020influential reference
• Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review

  2020cited by this paper
• Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.

  2020cited by this paper
• Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease

  2020cited by this paper
• Central reading of ulcerative colitis clinical trial videos using neural networks.

  2020cited by this paper
• Common and rare variant prediction and penetrance of IBD in a large, multi-ethnic, health system-based biobank cohort.

  2020cited by this paper
• The four epidemiological stages in the global evolution of inflammatory bowel disease

  2020cited by this paper
• Treat to target: The role of histologic healing in inflammatory bowel diseases: A systematic review and meta-analysis.

  2020cited by this paper
• Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

  2019cited by this paper
• Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.

  2019cited by this paper
• Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review

  2018cited by this paper
• Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity

  2018cited by this paper
• Variable generalization performance of a deep learning model to detect pneumonia in chest radiographs: A cross-sectional study

  2018cited by this paper
• Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.

  2017influential reference
• Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort

  2017cited by this paper
• Clinical Genomics in Inflammatory Bowel Disease.

  2017cited by this paper
• Oncostatin M drives intestinal inflammation in mice and its abundance predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease

  2017cited by this paper
• Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

  2016cited by this paper
• A Simplified Geboes Score for Ulcerative Colitis

  2016cited by this paper
• Relationships among injury, fibrosis, and time in human kidney transplants.

  2016cited by this paper
• Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

  2016cited by this paper
• Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

  2015cited by this paper
• The global burden of IBD: from 2015 to 2025

  2015influential reference
• Genetics of Inflammatory Bowel Diseases.

  2015cited by this paper
• The support of human genetic evidence for approved drug indications

  2015cited by this paper
• Pigeons (Columba livia) as Trainable Observers of Pathology and Radiology Breast Cancer Images

  2015cited by this paper
• A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia

  2014cited by this paper
• Phenotypic Manifestations of Inflammatory Bowel Disease Differ Between Hispanics and Non-Hispanic Whites: Results of a Large Cohort Study

  2013cited by this paper
• Bias in associations of emerging biomarkers with cardiovascular disease.

  2013cited by this paper
• Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.

  2012cited by this paper
• Molecular phenotypes of acute kidney injury in kidney transplants.

  2012cited by this paper
• Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta‐analysis of prospective studies

  2012cited by this paper
• Genome wide association (GWA) predictors of anti‐TNF&agr; therapeutic responsiveness in pediatric inflammatory bowel disease

  2009cited by this paper
• Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

  2009cited by this paper
• Association of TNFSF15 With Crohn's Disease in Koreans

  2008cited by this paper
• New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

  2007cited by this paper
• TNFSF15 is an ethnic‐specific IBD gene

  2007cited by this paper
• A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

  2006cited by this paper
• Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease.

  2005cited by this paper
• Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families.

  2004cited by this paper
• Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.

  2004cited by this paper
• International Variation in Histologic Grading Is Large, and Persistent Feedback Does Not Improve Reproducibility

  2003cited by this paper
• Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

  2001cited by this paper
• A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

  2000cited by this paper
• COLITIS

  1978cited by this paper

• No citing papers are available for this paper.